- Home
- ADMA vs ELP Comparison
ADMA vs ELP Comparison
Compare ADMA & ELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- ELP
- Stock Information
- Founded
- ADMA 2004
- ELP 1954
- Country
- ADMA United States
- ELP Brazil
- Employees
- ADMA N/A
- ELP N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- ELP Electric Utilities: Central
- Sector
- ADMA Health Care
- ELP Utilities
- Exchange
- ADMA Nasdaq
- ELP Nasdaq
- Market Cap
- ADMA 5.3B
- ELP 5.5B
- IPO Year
- ADMA N/A
- ELP 1997
- Fundamental
- Price
- ADMA $21.18
- ELP $6.45
- Analyst Decision
- ADMA Strong Buy
- ELP
- Analyst Count
- ADMA 4
- ELP 0
- Target Price
- ADMA $21.25
- ELP N/A
- AVG Volume (30 Days)
- ADMA 3.9M
- ELP 284.4K
- Earning Date
- ADMA 11-07-2024
- ELP 12-03-2024
- Dividend Yield
- ADMA N/A
- ELP 1.60%
- EPS Growth
- ADMA N/A
- ELP 43.89
- EPS
- ADMA 0.28
- ELP 0.19
- Revenue
- ADMA $382,809,000.00
- ELP $4,076,906,276.00
- Revenue This Year
- ADMA $60.41
- ELP N/A
- Revenue Next Year
- ADMA $13.09
- ELP $8.16
- P/E Ratio
- ADMA $75.56
- ELP $8.06
- Revenue Growth
- ADMA 63.39
- ELP 4.83
- 52 Week Low
- ADMA $3.60
- ELP $6.36
- 52 Week High
- ADMA $23.64
- ELP $10.64
- Technical
- Relative Strength Index (RSI)
- ADMA 59.66
- ELP 36.53
- Support Level
- ADMA $18.90
- ELP $6.36
- Resistance Level
- ADMA $21.70
- ELP $6.68
- Average True Range (ATR)
- ADMA 1.13
- ELP 0.12
- MACD
- ADMA 0.08
- ELP 0.01
- Stochastic Oscillator
- ADMA 51.48
- ELP 17.00
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About ELP Companhia Paranaense de Energia (COPEL) (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Holding and Services. Majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.